KDM6A and neoplasm: In many cancer models, the role of UTX as a tumor suppressor has been linked to epigenetic changes associated with UTX loss.4,7 Significant changes in enhancer and chromatin accessibility were observed in UTX knockout cancer models, and an enzyme activity-independent role has also been proposed for UTX as a tumor suppressor.4,7